| General Information of Drug Metabolite (DM) (ID: DM002436) |
| DM Name |
Valdecoxib metabolite M9-G
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2C9 (CYP2C9)
|
DME0019
|
| Unclear - Unclear |
Valdecoxib
|
[1] |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Unclear - Unclear |
Valdecoxib
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Valdecoxib |
DR1666
|
Approved |
Osteoarthritis |
|
|
| Parecoxib |
DR1242
|
Phase 4 |
Anaesthesia |
|
|
| References |
| 1 |
Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in human Drug Metab Dispos. 2002 Sep;30(9):1013-21. doi: 10.1124/dmd.30.9.1013.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
